封面
市場調查報告書
商品編碼
1629855

全球磷蝦油市場 - 2024-2031

Global Krill Oil Market - 2024-2031

出版日期: | 出版商: DataM Intelligence | 英文 211 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年全球磷蝦油市場規模達2.7143億美元,預計2031年將達到11.1405億美元,2024-2031年預測期間複合年成長率為19.7%。

近年來,由於消費者對其健康益處的認知不斷提高,特別是其高濃度的 omega-3 脂肪酸(EPA 和 DHA)、磷脂質和蝦紅素等抗氧化劑,磷蝦油市場出現了顯著成長。這些成分具有多種健康優勢,包括改善心血管健康、增強認知功能和抗發炎作用,使磷蝦油成為注重健康的消費者追捧的補充劑。

心臟病、肥胖和認知能力下降等與生活方式相關的健康問題日益普遍,刺激了對預防性健康解決方案的需求,進一步推動了市場成長。磷蝦油中的 omega-3 脂肪酸,特別是 EPA 和 DHA,已因其心臟保護作用而被廣泛研究,例如降低三酸甘油酯、降低血壓、改善內皮功能和降低血栓形成的風險。

磷蝦油的健康益處在促進整體心血管健康以及降低心臟病和中風的風險方面發揮著重要作用,使磷蝦油成為許多消費者健康習慣的重要組成部分。此外,產品創新,包括針對心臟、關節或認知健康等特定健康問題的新配方,使公司能夠擴大業務範圍並迎合更廣泛的具有健康意識的個人,進一步推動市場的成長。

動力學

慢性病盛行率上升

心臟病、糖尿病、癌症和呼吸系統疾病等慢性疾病是全球主要健康問題,據世界衛生組織稱,造成全球 74% 的死亡,其中低收入和中等收入國家受到的影響尤為嚴重。主要風險因素包括不良飲食、缺乏身體活動、吸煙和空氣污染。磷蝦油富含 omega-3 脂肪酸(EPA 和 DHA)和抗氧化劑蝦紅素,已成為有益的補充劑。

它有助於減少炎症,改善心臟健康,支持關節功能,並控制糖尿病等代謝疾病,提供一種對抗慢性疾病的自然方法。在服務不足的美國社區,由於獲得醫療保健的機會有限,慢性病更加普遍,磷蝦油可以作為一種具有成本效益的解決方案。它的抗發炎特性有助於降低心臟病風險,提高胰島素敏感性,並防止氧化壓力,使患有關節炎和呼吸道疾病等疾病的人受益。

公司採取的策略

在產品創新和策略合作夥伴關係的推動下,磷蝦油市場正在快速成長。該公司正在開發結合 omega-3、抗氧化劑和維生素的專門配方,以針對關節健康和認知功能等領域。例如,NYO3於2024年在中國推出多用途磷蝦油產品,專注於女性和運動用戶的關節健康,而Aker BioMarine的Superba Boost磷蝦油因與膝蓋疼痛和骨關節炎相關的健康聲明而在澳大利亞獲得ARTG批准。

戰略合作進一步擴大市場範圍。 Aker BioMarine 於 2024 年與 Kilyos Nutrition 合作,在巴西分銷磷蝦油,確保永續採購,而 Brenntag Specialties 則擴大了在東南亞的分銷。這些合作關係幫助公司開拓新市場,增強競爭地位,並滿足對永續健康補充劑不斷成長的需求。

磷蝦油的副作用

磷蝦油面臨阻礙其市場成長的多項挑戰,主要是由於副作用。常見的問題是胃腸道不適,例如胃部不適、腹瀉、腹脹和胃灼熱,這可能會使補充劑難以耐受。在某些情況下,高劑量可能會使這些症狀惡化,導致使用者停止使用。此外,磷蝦油可以放鬆下食道括約肌,導致胃灼熱和胸部灼熱感。

過敏反應的範圍從蕁麻疹等輕微症狀到呼吸困難等嚴重問題。有些使用者會經歷魚腥味餘韻或魚打嗝的感覺,尤其是在劑量較高的情況下。此外,磷蝦油中的 omega-3 含量可能具有血液稀釋作用,增加服用血液稀釋藥物的人出血的風險。還有有限的證據表明高劑量的磷蝦油可能會升高空腹血糖水平,這可能是糖尿病患者所關心的問題。

目錄

第 1 章:方法與範圍

第 2 章:定義與概述

第 3 章:執行摘要

第 4 章:動力學

  • 影響因素
    • 促進要素
      • 慢性病盛行率上升
      • 公司採取的策略
    • 限制
      • 與磷蝦油消耗相關的副作用
    • 機會
    • 影響分析

第 5 章:產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • DMI 意見

第 6 章:按形式

  • 膠囊
    • 軟膠囊
    • 硬凝膠
  • 粉末
  • 軟糖

第 7 章:按申請

  • 人類應用
    • 心血管健康
    • 改善循環
    • 心臟病發作和中風
    • 其他
    • 一般營養與健康
    • 女性健康
    • 經前症候群
    • 經期疼痛
    • 產前健康
    • 其他
    • 關節和骨骼健康
    • 骨關節炎
    • 骨質疏鬆症
    • 加入疼痛和炎症
    • 其他
    • 神經內科健康
    • 認知
    • 心理健康
    • 其他
    • 皮膚健康
    • 抗衰老
    • 水合和彈性
    • 其他
    • 眼睛健康
    • 乾眼症
    • 發炎
    • 其他
    • 其他
  • 動物應用
    • 營養
    • 皮膚和毛髮健康
    • 心臟健康
    • 骨骼和關節健康
    • 其他

第 8 章:按銷售管道

  • 企業對企業
  • 企業對消費者

第 9 章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 10 章:競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 11 章:公司簡介

  • AKER BIOMARINE.
    • 公司概況
    • 自然組合和描述
    • 財務概覽
    • 主要進展
  • Biocorp Co., Ltd.
  • Rimfrost AS
  • NYO3 INTERNATIONAL AS
  • Onnit Labs, Inc.
  • Transparent Labs
  • Nurtigold
  • Shandong Kangjing Marine Biotechnology Co., Ltd
  • Coastside Bio Resources
  • Reckitt Benckiser Group plc.
  • Artic Light Products AS
  • NWC Naturals Inc.

第 12 章:附錄

簡介目錄
Product Code: FB2350

Overview

Global Krill Oil Market reached US$ 271.43 million in 2023 and is expected to reach US$ 1,114.05 million by 2031, growing with a CAGR of 19.7% during the forecast period 2024-2031.

The krill oil market has seen significant growth in recent years, driven by rising consumer awareness of its health benefits, particularly its high concentration of omega-3 fatty acids (EPA and DHA), phospholipids, and antioxidants like astaxanthin. These components contribute to various health advantages, including improved cardiovascular health, enhanced cognitive function, and anti-inflammatory effects, making krill oil a sought-after supplement among health-conscious consumers.

The increasing prevalence of lifestyle-related health issues, such as heart disease, obesity, and cognitive decline, has spurred demand for preventive health solutions, further propelling market growth. The omega-3 fatty acids in krill oil, particularly EPA and DHA, have been extensively studied for their cardioprotective effects, such as lowering triglycerides, reducing blood pressure, improving endothelial function, and decreasing the risk of thrombosis.

The health benefits play a significant role in promoting overall cardiovascular health and reducing the risk of heart attacks and strokes, making krill oil an essential part of many consumers' wellness routines. Additionally, product innovations, including new formulations targeting specific health concerns like heart, joint, or cognitive health, have allowed companies to expand their reach and cater to a wider range of health-conscious individuals, further driving the market's growth.

Dynamics

Rising Prevalence of Chronic Diseases

Chronic diseases like heart disease, diabetes, cancer, and respiratory disorders are major global health concerns, causing 74% of deaths worldwide according to WHO, with a disproportionate impact on low- and middle-income countries. Key risk factors include poor diets, physical inactivity, tobacco use, and air pollution. Krill oil, rich in omega-3 fatty acids (EPA and DHA) and the antioxidant astaxanthin, has emerged as a beneficial supplement.

It helps reduce inflammation, improve heart health, support joint function, and manage metabolic conditions like diabetes, offering a natural way to combat chronic diseases. In underserved US communities, where chronic diseases are more prevalent due to limited access to healthcare, krill oil can serve as a cost-effective solution. Its anti-inflammatory properties help reduce heart disease risk, improve insulin sensitivity, and protect against oxidative stress, benefiting individuals with conditions like arthritis and respiratory diseases.

Strategies Adopted by the Companies

The krill oil market is growing rapidly, driven by product innovation and strategic partnerships. Companies are developing specialized formulations combining omega-3s, antioxidants, and vitamins to target areas like joint health and cognitive function. For instance, NYO3 launched multipurpose krill oil products in China in 2024, focusing on joint health for women and sports users, while Aker BioMarine's Superba Boost Krill Oil gained ARTG approval in Australia for health claims related to knee pain and osteoarthritis.

Strategic collaborations are further expanding market reach. Aker BioMarine partnered with Kilyos Nutrition in 2024 to distribute krill oil in Brazil, ensuring sustainable sourcing, while Brenntag Specialties expanded distribution in Southeast Asia. These partnerships help companies tap into new markets, strengthen their competitive position, and meet the growing demand for sustainable health supplements.

Side Effects of Krill Oil

Krill oil faces several challenges that hinder its market growth, primarily due to side effects. One common issue is gastrointestinal discomfort, such as upset stomach, diarrhea, bloating, and heartburn, which can make the supplement difficult to tolerate. In some cases, high doses may worsen these symptoms, leading users to discontinue use. Additionally, krill oil can relax the lower esophageal sphincter, contributing to heartburn and a burning sensation in the chest.

Allergic reactions can range from mild symptoms like hives to severe issues like difficulty breathing. The fishy aftertaste or fish burps that some users experience, especially with higher doses. Furthermore, krill oil's omega-3 content may have a blood-thinning effect, increasing the risk of bleeding for individuals taking blood-thinning medications. There is also limited evidence suggesting that high doses of krill oil could raise fasting blood glucose levels, which may be a concern for people with diabetes.

Segment Analysis

The global krill oil market is segmented based on form, application, sales channel, and region.

Convenience, Efficacy, and Consumer Preference of Capsules

The global krill oil market is segmented based on form into capsules, oil, powder, and gummies. The capsule formulations dominate the market and are driven by the convenience, efficacy, and consumer preference for controlled dosages. Soft gel capsules dominate the market due to their superior bioavailability, ease of swallowing, and aesthetic appeal. It is popular among brands like WOW Life Science, Carbamide Forte, and Superba Krill.

The soft gels offer a palatable solution with minimal fishy aftertaste, making them a preferred choice for health-conscious consumers. Hard gel capsules are gaining traction among consumers who prioritize clean-label, allergen-free products. These capsules, valued for their simplicity and structural integrity, offer customization opportunities for targeted formulations like cognitive enhancement or joint support.

Geographical Penetration

High Demand for Products with Health Benefits in North America

The North American krill oil market has seen significant growth, driven by increasing awareness of its health benefits, especially its superior bioavailability compared to fish oil. The 2023 CRN Dietary Supplement Survey revealed that 77% of Americans use dietary supplements, with Omega-3 products among the most popular. Cardiovascular health is a key driver, as heart disease remains the leading cause of death in US, claiming over 659,000 lives annually (CDC, 2023).

Krill oil, rich in EPA and DHA, improves lipid profiles and reduces inflammation, lowering risks of heart attacks and strokes. A 2022 study in The American Journal of Clinical Nutrition confirmed that krill oil's phospholipid-bound Omega-3s are more bioavailable than triglyceride-bound Omega-3s in fish oil. Krill oil is also popular for general wellness, particularly in addressing women's health issues like PMS and prenatal care. A 2022 NCBI study showed Omega-3s help reduce PMS symptoms.

Joint health is another key market segment, with over 54 million US adults suffering from arthritis (2023 Arthritis Foundation Report). Krill oil's anti-inflammatory properties support those with arthritis and osteoporosis, improving mobility. The market continues to grow due to the trend toward preventive healthcare and consumer preference for sustainable, eco-friendly products. The 2023 GOED report highlights steady growth in Omega-3 consumption, and innovations are boosting consumer acceptance.

Competitive Landscape

The major global players in the market include AKER BIOMARINE, Biocorp Co., Ltd., Rimfrost AS, NYO3 INTERNATIONAL AS, Onnit Labs, Inc., Transparent Labs, Nurtigold, Shandong Kangjing Marine Biotechnology Co., Ltd, Coastside Bio Resources, Reckitt Benckiser Group plc., Artic Light Products AS, and NWC Naturals Inc.

Sustainability Analysis

Krill oil is gaining popularity as an eco-friendly alternative to traditional marine oils, with sustainability being a key selling point. Krill are abundant and reproduce quickly, making them a renewable resource for oil extraction. Leading suppliers, such as Aker BioMarine, follow Marine Stewardship Council (MSC)-certified sustainable fishing practices, ensuring healthy krill populations and protected marine ecosystems.

Sustainability is a key marketing strategy, especially for eco-conscious consumers, as seen with Schiff Vitamins, which sources its krill oil from certified sustainable fisheries. However, the risk of overharvesting grows with rising demand. Since krill are vital to marine ecosystems, sustainable management is crucial to maintain balance. Suppliers must uphold strict sustainability standards, ensure transparency, and innovate eco-friendly production methods as the market expands.

By Form

  • Capsules
    • Softgels
    • Hardgels
  • Oil
  • Powder
  • Gummies

By Application

  • Human Applications
    • Cardiovascular Health
  • Circulation Improvement
  • Heart Attacks and Strokes
  • Others
    • General Nutrition and Wellness
    • Women Health
  • Premenstrual Syndrome
  • Period Pains
  • Prenatal Health
  • Others
    • Joint and Bone Health
  • Osteoarthritis
  • Osteoporosis
  • Join Pains and Inflammation
  • Others
    • Neurology Health
  • Cognition
  • Mental Health
  • Others
    • Skin Health
  • Anti-Aging
  • Hydration and Elasticity
  • Others
    • Eye Health
  • Dry Eye
  • Inflammation
  • Others
    • Others
  • Animal Applications
    • Nutrition
    • Skin and Coat Health
    • Heart Health
    • Bone and Joint Health
    • Others

By Sales Channel

  • B2B
  • B2C

By Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In February 2024, Aker BioMarine partnered with Kilyos Nutrition to introduce Superba Krill oil in Brazil, focusing on heart, liver, pregnancy, and cognitive health. This collaboration aims to meet the demand for sustainable, science-backed alternatives to fish oil, expanding Aker BioMarine's presence in the Brazilian market.
  • In July 2024, NYO3 is expanding in China with a new series of multipurpose krill oil products for women and sports enthusiasts. The innovative supplement, infused with collagen and hyaluronic acid, aims to enhance eye and vision health, capitalizing on the growing consumer awareness of omega-3 benefits beyond traditional fish oil.
  • In July 2022, Aker BioMarine secured FDA approval for its krill products with astaxanthin as color additives in fish feeds, enhancing salmon flesh color. This approval benefits North American salmon farming, improving feed uptake, growth, health, and fillet quality with QRILL Aqua and QRILL High Protein.

Why Purchase the Report?

  • To visualize the global krill oil market segmentation based on form, application, sales channel and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous krill oil market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global krill oil market report would provide approximately 68 tables, 53 figures and 211 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Form
  • 3.2. Snippet by Application
  • 3.3. Snippet by Sales Channel
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Prevalence of Chronic Diseases
      • 4.1.1.2. Strategies Adopted by the Companies
    • 4.1.2. Restraints
      • 4.1.2.1. Side Effects Associated with Krill Oil Consumption
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. By Form

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 6.1.2. Market Attractiveness Index, By Form
  • 6.2. Capsules
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Softgels
    • 6.2.4. Hardgels
  • 6.3. Oil
  • 6.4. Powder
  • 6.5. Gummies

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Human Applications
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Cardiovascular Health
    • 7.2.4. Circulation Improvement
    • 7.2.5. Heart Attacks and Strokes
    • 7.2.6. Others
    • 7.2.7. General Nutrition and Wellness
    • 7.2.8. Women Health
    • 7.2.9. Premenstrual Syndrome
    • 7.2.10. Period Pains
    • 7.2.11. Prenatal Health
    • 7.2.12. Others
    • 7.2.13. Joint and Bone Health
    • 7.2.14. Osteoarthritis
    • 7.2.15. Osteoporosis
    • 7.2.16. Join Pains and Inflammation
    • 7.2.17. Others
    • 7.2.18. Neurology Health
    • 7.2.19. Cognition
    • 7.2.20. Mental Health
    • 7.2.21. Others
    • 7.2.22. Skin Health
    • 7.2.23. Anti-Aging
    • 7.2.24. Hydration and Elasticity
    • 7.2.25. Others
    • 7.2.26. Eye Health
    • 7.2.27. Dry Eye
    • 7.2.28. Inflammation
    • 7.2.29. Others
    • 7.2.30. Others
  • 7.3. Animal Applications
    • 7.3.1. Nutrition
    • 7.3.2. Skin and Coat Health
    • 7.3.3. Heart Health
    • 7.3.4. Bone and Joint Health
    • 7.3.5. Others

8. By Sales Channel

  • 8.1. Introduction
  • 8.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
  • 8.3. Market Attractiveness Index, By Sales Channel
  • 8.4. B2B
    • 8.4.1. Introduction
    • 8.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.5. B2C

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. US
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. AKER BIOMARINE.
    • 11.1.1. Company Overview
    • 11.1.2. Nature Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Biocorp Co., Ltd.
  • 11.3. Rimfrost AS
  • 11.4. NYO3 INTERNATIONAL AS
  • 11.5. Onnit Labs, Inc.
  • 11.6. Transparent Labs
  • 11.7. Nurtigold
  • 11.8. Shandong Kangjing Marine Biotechnology Co., Ltd
  • 11.9. Coastside Bio Resources
  • 11.10. Reckitt Benckiser Group plc.
  • 11.11. Artic Light Products AS
  • 11.12. NWC Naturals Inc.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us